Liposome-encapsulated antibiotics.

[1]  P. Gangadharam,et al.  An acute infection model for Mycobacterium intracellulare disease using beige mice: preliminary results. , 2015, The American review of respiratory disease.

[2]  T. Redelmeier,et al.  Development of a Liposome Formulation of Ethambutol , 2004, Antimicrobial Agents and Chemotherapy.

[3]  R. Pandey,et al.  Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis. , 2004, International journal of antimicrobial agents.

[4]  Sanyog Jain,et al.  Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. , 2004, International journal of pharmaceutics.

[5]  N. Düzgüneş,et al.  Efficacies of cyclodextrin-complexed and liposome-encapsulated clarithromycin against Mycobacterium avium complex infection in human macrophages. , 2003, International journal of pharmaceutics.

[6]  D. Mitchison,et al.  The activity of low-clearance liposomal amikacin in experimental murine tuberculosis. , 2001, The Journal of antimicrobial chemotherapy.

[7]  E. Winer,et al.  Liposomal anthracyclines for breast cancer. , 2001, Seminars in oncology.

[8]  R. Schiffelers,et al.  In vivo synergistic interaction of liposome-coencapsulated gentamicin and ceftazidime. , 2001, The Journal of pharmacology and experimental therapeutics.

[9]  M. T. ten Kate,et al.  Improved Efficacy of Ciprofloxacin Administered in Polyethylene Glycol-Coated Liposomes for Treatment of Klebsiella pneumoniae Pneumonia in Rats , 2001, Antimicrobial Agents and Chemotherapy.

[10]  J. Rossi,et al.  ENHANCED INHIBITION OF HIV-1 REPLICATION IN MACROPHAGES BY ANTISENSE OLIGONUCLEOTIDES, RIBOZYMES AND ACYCLIC NUCLEOSIDE PHOSPHONATE ANALOGS DELIVERED IN pH-SENSITIVE LIPOSOMES , 2001, Nucleosides, nucleotides & nucleic acids.

[11]  F. Portaels,et al.  Therapeutic Efficacy of Liposomal Rifabutin in a Mycobacterium avium Model of Infection , 2000, Antimicrobial Agents and Chemotherapy.

[12]  J. H. Zhang,et al.  A novel method to prepare liposomes containing amikacin. , 1999, Journal of microencapsulation.

[13]  B. Finlay,et al.  Intracellular Delivery and Antibacterial Activity of Gentamicin Encapsulated in pH-Sensitive Liposomes , 1998, Antimicrobial Agents and Chemotherapy.

[14]  R. Müller,et al.  Rationale for and Efficacy of Prolonged-Interval Treatment Using Liposome-Encapsulated Amikacin in Experimental Mycobacterium avium Infection , 1998, Antimicrobial Agents and Chemotherapy.

[15]  H. Yang,et al.  Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice , 1997, Antimicrobial agents and chemotherapy.

[16]  K. Joshi,et al.  Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice , 1997, Antimicrobial agents and chemotherapy.

[17]  S. Simões,et al.  Sterically Stabilized pH-sensitive Liposomes , 1997, The Journal of Biological Chemistry.

[18]  R. Gomez-flores,et al.  Therapeutic efficacy of liposomal clofazimine against Mycobacterium avium complex in mice depends on size of initial inoculum and duration of infection , 1997, Antimicrobial agents and chemotherapy.

[19]  E. Hersh,et al.  Liposomal amikacin: improved treatment of Mycobacterium avium complex infection in the beige mouse model. , 1996, The Journal of antimicrobial chemotherapy.

[20]  P. Gangadharam,et al.  Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin , 1996, Antimicrobial agents and chemotherapy.

[21]  M. Arboix,et al.  Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits. , 1995, American journal of veterinary research.

[22]  Y. Oh,et al.  Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection , 1995, Antimicrobial agents and chemotherapy.

[23]  A. Tulpule,et al.  Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  P. Gangadharam,et al.  Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes , 1995, Antimicrobial agents and chemotherapy.

[25]  L. Heifets,et al.  Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium , 1994, Antimicrobial Agents and Chemotherapy.

[26]  I. Orme,et al.  Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages. , 1994, Journal of immunology.

[27]  E. Vittinghoff,et al.  The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients--a prospective study. , 1994, The Journal of infectious diseases.

[28]  H. P. Gupta,et al.  Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice , 1994, Antimicrobial Agents and Chemotherapy.

[29]  D. Nicolau,et al.  Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages , 1994, Antimicrobial Agents and Chemotherapy.

[30]  J. Fierer,et al.  Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis , 1993, Antimicrobial Agents and Chemotherapy.

[31]  G. Storm,et al.  Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue. , 1993, The Journal of infectious diseases.

[32]  D. Friend,et al.  Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages , 1992, Antimicrobial Agents and Chemotherapy.

[33]  M. Woodle,et al.  Sterically stabilized liposomes. , 1992, Biochimica et biophysica acta.

[34]  G. Storm,et al.  Enhanced localization of liposomes with prolonged blood circulation time in infected lung tissue. , 1992, Biochimica et biophysica acta.

[35]  S. Piscitelli,et al.  Clarithromycin and azithromycin: new macrolide antibiotics. , 1992, Clinical pharmacy.

[36]  P. Gangadharam,et al.  Activity of free and liposome encapsulated streptomycin against Mycobacterium avium complex (MAC) inside peritoneal macrophages. , 1991, Journal of Antimicrobial Chemotherapy.

[37]  P. Gangadharam,et al.  Chemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice. , 1991, The Journal of antimicrobial chemotherapy.

[38]  D. Friend,et al.  Treatment of Mycobacterium avium-intracellulare complex infection in beige mice with free and liposome-encapsulated streptomycin: role of liposome type and duration of treatment. , 1991, The Journal of infectious diseases.

[39]  T M Allen,et al.  Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.

[40]  C. Truffot-Pernot,et al.  Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages , 1991, Antimicrobial Agents and Chemotherapy.

[41]  Horsburgh Cr.  Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. , 1991, The New England journal of medicine.

[42]  P. Gangadharam,et al.  Differential effects of free and liposome encapsulated amikacin on the survival of Mycobacterium avium complex in mouse peritoneal macrophages. , 1990, Tubercle.

[43]  L. Bermudez,et al.  Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides. , 1990, The Journal of infectious diseases.

[44]  D. Papahadjopoulos,et al.  Endocytosis of liposomes by macrophages: binding, acidification and leakage of liposomes monitored by a new fluorescence assay. , 1990, Biochimica et biophysica acta.

[45]  R. Debs,et al.  Interaction of antimycobacterial and anti-pneumocystis drugs with phospholipid membranes. , 1990, Chemistry and physics of lipids.

[46]  Y. Barenholz,et al.  Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. , 1989, European journal of cancer & clinical oncology.

[47]  M. Cynamon,et al.  Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige mice , 1989, Antimicrobial Agents and Chemotherapy.

[48]  R. Eng,et al.  Diagnosis of Mycobacterium bacteremia in patients with acquired immunodeficiency syndrome by direct examination of blood films , 1989, Journal of clinical microbiology.

[49]  P. Gangadharam,et al.  Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice , 1988, Antimicrobial Agents and Chemotherapy.

[50]  L. Bermudez,et al.  Intracellular killing of Mycobacterium avium complex by rifapentine and liposome-encapsulated amikacin. , 1987, The Journal of infectious diseases.

[51]  G. Storm,et al.  Liposomes in treatment of infectious diseases , 1987, Pharmaceutisch Weekblad.

[52]  L. Frankel,et al.  Treatment of hepatosplenic candidiasis with liposomal-amphotericin B. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  T. Daemen,et al.  In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide. , 1986, Cancer research.

[54]  D. Armstrong,et al.  Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. , 1986, Annals of internal medicine.

[55]  B. Polsky,et al.  Treatment of infections in patients with the acquired immunodeficiency syndrome. , 1985, Annals of internal medicine.

[56]  L. Huang,et al.  Efficient cytoplasmic delivery of a fluorescent dye by pH-sensitive immunoliposomes , 1985, The Journal of cell biology.

[57]  T. Tadakuma,et al.  Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes , 1985, Antimicrobial Agents and Chemotherapy.

[58]  I. Bakker-Woudenberg,et al.  Free versus liposome-entrapped ampicillin in treatment of infection due to Listeria monocytogenes in normal and athymic (nude) mice. , 1985, The Journal of infectious diseases.

[59]  M. Iseman,et al.  Disseminated Infection with Mycobacterium avium‐intracellulare: A REPORT OF 13 CASES AND A REVIEW OF THE LITERATURE , 1985, Medicine.

[60]  D. Friend,et al.  Physicochemical characterization of large unilamellar phospholipid vesicles prepared by reverse-phase evaporation. , 1983, Biochimica et biophysica acta.

[61]  C. Nathan,et al.  A simple method for counting adherent cells: application to cultured human monocytes, macrophages and multinucleated giant cells. , 1983, Journal of immunological methods.

[62]  C. Bucana,et al.  Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. , 1982, Cancer research.

[63]  T. Konoshita,et al.  Post-column derivatization of guanidino compounds in high-performance liquid chromatography using ninhydrin. , 1981, Journal of chromatography.

[64]  S. Siddiqi,et al.  Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis , 1981, Journal of clinical microbiology.

[65]  G. R. Bartlett.  Phosphorus assay in column chromatography. , 1959, The Journal of biological chemistry.

[66]  S. Simões,et al.  Sterically stabilized ph-sensitive liposomes. , 2004, Methods in enzymology.

[67]  N. Düzgüneş.  Preparation and quantitation of small unilamellar liposomes and large unilamellar reverse-phase evaporation liposomes. , 2003, Methods in enzymology.

[68]  B. Dupont.  Overview of the lipid formulations of amphotericin B. , 2002, The Journal of antimicrobial chemotherapy.

[69]  A. L. Baş,et al.  Efficacies of free and liposome-encapsulated enrofloxacin (Baytril®) against Staphylococcus aureus infection in Turkish Shepherd Dog neutrophils in vitro , 2000 .

[70]  D. Eisen,et al.  Mycobacterium avium complex causing endobronchial disease in AIDS patients after partial immune restoration. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[71]  N. Düzgüneş.  Treatment of human immunodeficiency virus, Mycobacterium avium and Mycobacterium tuberculosis infections by liposome-encapsulated drugs**This chapter is dedicated to the memories of my father Professor Orhan Düzgüneş, and my father-in-law Professor John Flasher. , 1998 .

[72]  D. Schlossberg.  Azithromycin and clarithromycin. , 1995, The Medical clinics of North America.

[73]  P. Gangadharam,et al.  Liposome-mediated therapy of human immunodeficiency virus type-1 and mycobacterium infections , 1995 .

[74]  R. Straubinger.  pH-sensitive liposomes for delivery of macromolecules into cytoplasm of cultured cells. , 1993, Methods in enzymology.

[75]  G. Scherphof.  In Vivo Behavior of Liposomes: Interactions with the Mononuclear Phagocyte System and Implications for Drug Targeting , 1991 .

[76]  I. Bakker-Woudenberg,et al.  Liposomes as Drug Carriers to Liver Macrophages: Fundamental and Therapeutic Aspects , 1986 .

[77]  D. Papahadjopoulos,et al.  pH‐sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules , 1985, FEBS letters.

[78]  J. Dijkstra,et al.  Interaction of liposomes with Kupffer cells in vitro. , 1984, Experimental cell research.

[79]  Ladigina Ga,et al.  Antibacterial activity of liposome-entrapped streptomycin in mice infected with mycobacterium tuberculosis. , 1982 .

[80]  F. Szoka,et al.  Preparation of unilamellar liposomes of intermediate size (0.1-0.2 mumol) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. , 1980, Biochimica et biophysica acta.